HBV'de Tedavi - EKMUD

Acinetobacter baumannii clinical isolates. J Antimicrob
Chemother 2007;60:421-3.
43. Tasbakan M, Pullukcu H, Sipahi OR, Yamazhan T, Ulusoy
S. Nitrofurantoin in the treatment of Extended-spectrum
Beta-lactamase (ESBL) producing E. coli related lower
urinary tract infection (LUTI). 48.ICAAC&46. IDSA, 2008,
poster L494.
44. Taşbakan M, Pullukçu H, Yamazhan T, Arda B, Ulusoy S.
Toplum kökenli üriner sistem enfeksiyonlarından soyutlanan
Escherichia coli suşlarına fosfomisinin invitro etkinliğinin
diğer antibiyotiklerle karşılaştırılması. ANKEM
2004;18:216-9.
45. Taşbakan MI, Pullukçu H, Sipahi OR, Yamazhan T, Arda B,
Ulusoy S. Pooled analysis of resistance patterns of
Escherichia coli Strains isolated from urine cultures in
Turkey: Comparison of 1997-2001 and 2002-2007
Periods. Turkish Medical Science (basımda).
46. Tasbakan MS, Pullukcu H, Ekren PK, Oz AT, Midilli M,
Aydemir S, et al. Colistin use in ventilator-associated pneumonia
due to panresistant Pseudomonas aeruginosa
and Acinetobacter baumannii. Mikrobiyol Bul 2009;43:61-
70.
47. Tasbakan MS, Pullukcu H, Sipahi OR, Tasbakan M,
Aydemir S, Bacakoglu F. Tigecycline in the treatment of
multidrug-resistant Acinetobacter baumannii pneumonia.
20th European Congress of Clinical Microbiology and
Infectious Diseases (ECCMID), 2010, Vienna, oral presentation
510.
Hüsnü Pullukçu
48. Tripodi MF, Durante-Mangoni E, Fortunato R, Utili R,
Zarrilli R. Comparative activities of colistin, rifampicin,
imipenem and sulbactam/ampicillin alone or in combination
against epidemic multidrug-resistant Acinetobacter
baumannii isolates producing OXA-58 carbapenemases.
Int J Antimicrob Agents 2007;30:537-40.
49. Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori
E, Leone F, et al. Bloodstream infections caused by extended-spectrum-
beta-lactamase-producing Klebsiella pneumoniae:
risk factors, molecular epidemiology, and clinical
outcome. Antimicrob Agents Chemother 2006;
50:498-504.
50. Tunçcan ÖG, Keten DT, Dizbay M, Hızel K. Hastane kaynaklı
Escherichia coli ve Klebsiella suşlarının ertapenem ve
diğer antibiyotiklere duyarlılığı. ANKEM 2008;22:188-
192.
51. Yamada S, Hyo Y, Ohmori S, Ohuchi M. Role of ciprofloxacin
in its synergistic effect with fosfomycin on drugresistant
strains of Pseudomonas aeruginosa.
Chemotherapy 2007;53:202-9.
52. Yilmaz N, Agus N, Yurtsever SG, Pullukcu H, Gulay Z,
Coskuner A, et al. Prevalence and antimicrobial susceptibility
of Escherichia coli in outpatient urinary isolates in
Izmir, Turkey. Med Sci Monit 2009;15:PI61-5.
3. Türkiye EKMUD Bilimsel Platformu 187